Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.5 USD | -0.01% | -1.54% | +9.21% |
Apr. 17 | JonesTrading Starts Achieve Life Sciences With Buy Rating, $20 Price Target | MT |
Mar. 28 | Transcript : Achieve Life Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 257K | Capitalization | 154M |
---|---|---|---|---|---|
Net income 2024 * | -33M | Net income 2025 * | -37M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 599 x |
P/E ratio 2024 * |
-4.24
x | P/E ratio 2025 * |
-4.6
x | Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.72% |
Latest transcript on Achieve Life Sciences, Inc.
1 day | -0.56% | ||
1 week | -1.54% | ||
Current month | -1.00% | ||
1 month | -3.65% | ||
3 months | -1.11% | ||
6 months | +12.49% | ||
Current year | +9.21% |
Managers | Title | Age | Since |
---|---|---|---|
John Bencich
CEO | Chief Executive Officer | 47 | 14-07-31 |
Richard Stewart
CHM | Chairman | 65 | 15-04-30 |
Cindy Jacobs
PSD | President | 66 | 08-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vaughn Himes
BRD | Director/Board Member | 63 | 22-03-13 |
Thomas King
BRD | Director/Board Member | 69 | 23-03-28 |
Cindy Jacobs
PSD | President | 66 | 08-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 4.5 | -0.01% | 7 322 |
24-04-23 | 4.5 | +2.04% | 51,613 |
24-04-22 | 4.41 | -2.22% | 82,081 |
24-04-19 | 4.51 | -1.31% | 35,387 |
24-04-18 | 4.57 | 0.00% | 77,779 |
Delayed Quote Nasdaq, April 24, 2024 at 10:07 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.21% | 154M | |
+4.97% | 43.43B | |
+47.87% | 41.69B | |
+10.15% | 41.31B | |
-10.82% | 27.14B | |
+9.75% | 25.28B | |
-24.34% | 18.47B | |
+34.89% | 12.59B | |
+2.32% | 12.33B | |
+8.56% | 11.03B |
- Stock Market
- Equities
- ACHV Stock